Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,468 JPY | -1.02% | -0.89% | +6.84% |
Mar. 27 | Japan's Idemitsu, Mitsui Chemicals may consolidate ethylene plants in Chiba | RE |
Mar. 26 | Vietnam's largest refinery to boost operating capacity by 15%-20% | RE |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in debt and has limited leeway for investment
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.84% | 5.47B | B+ | ||
+5.41% | 106B | A- | ||
-4.19% | 64.74B | A- | ||
+73.33% | 49.34B | B | ||
+17.24% | 39.15B | B | ||
+6.13% | 32.86B | A- | ||
+12.77% | 20.29B | B- | ||
+15.03% | 17.21B | C+ | ||
+19.06% | 15.28B | B- | ||
+6.28% | 14.58B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4183 Stock
- Ratings Mitsui Chemicals, Inc.